Genor Biopharma : 【ASCO 2023】LEONARDA-1 data suggest that Lerociclib (GB491) may become a more reliable clinical option
05 Jun, 2023 【ASCO 2023】LEONARDA-1 data suggest that Lerociclib may become a more reliable clinical option American Society... | June 5, 2023
Source: marketscreener.com